Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by fairweather1on Apr 15, 2013 9:55am
289 Views
Post# 21254047

below $2.75 - crazy!

below $2.75 - crazy!

At March 31, this company could probably wind up operations and still pay every shareholder off at over $2 per share (and that is giving plant/equip very little value).  Given the cost to set up this sub-assembly business, there is no way Ford or an outsider is going to take over the current contract.  So even if earnings continue at just 2/3 last year's for the remainder of the contract (assuming no wind or other contracts) to june 2014 and you assume plant/equip is only worth pennies on the dollar,

BY MY CALCULATIONS, THE COMPANY COULD WIND UP OPERATIONS AND PAY US ALL $2.75 PER SHARE.

That is -- realisitcally IMO -- worst case scenario...and people are selling below $2.75 right now.  Where is Donville at?

 

Bullboard Posts